Hi Solaris,
my understanding is that they will begin recruitment for the phase 2 trial PRIOR to the completion of the bioMUSE study, however I imagine that the endpoints for the trial will have to be settled on with the FDA ( using those studies) prior to the start of actual dosing of patients.
Ann: Alterity to present at Global Life Science Conference, page-6
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $1.786K | 516.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 33026800 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 126756613 | 19 |
View Market Depth
| Last trade - 11.58am 09/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |